Companies / Tibira Therapeutics, Inc.
Tibira Therapeutics, Inc.
RGDOTBRACIK 1311596
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| May 4, 2015 | Domain Parters VII L P 10% owner | Buy Open-market buy | Common Stock | $2.95M | +278K +8.48% | 3,553,322 | high |
| May 4, 2015 | Domain Associates 10% owner | Other Other (per filing) | Common Stock | — | +36K +1897.59% | 38,094 | low |
| Dec 3, 2014 | Metzger Michael A CEO | Grant Grant or award | Stock Option (right to buy) | — | +838K | 837,531 | low |
| Jan 1, 2015 | Podlesak Dennis Director | Grant Grant or award | Common Stock (right to buy) | — | +159K | 159,261 | low |
| Jan 1, 2015 | Gopka Anton Director | Grant Grant or award | Common Stock (right to buy) | — | +159K | 159,261 | low |
| Jan 1, 2015 | Legault Pierre Director | Grant Grant or award | Common Stock (right to buy) | — | +159K | 159,261 | low |
| Jan 1, 2015 | Mendelsohn Michael Director | Grant Grant or award | Common Stock (right to buy) | — | +159K | 159,261 | low |
| Jan 1, 2015 | Elsey R Don Executive | Grant Grant or award | Common Stock (right to buy) | — | +93K | 92,902 | low |